BioZapetite 90ct

BioZapetite features orforglipron (6 mg), a breakthrough oral, small-molecule GLP-1 receptor agonist created for investigational applications. In contrast to peptide-based GLP-1 formulations, orforglipron offers oral absorption without fasting prerequisites or fluid limitations, while delivering potent activity in metabolic and weight management pathways.

Its integrated approach is formulated to:

• Enhance glucose clearance & improve insulin responsiveness
• Support healthy weight management & natural satiety
• Strengthen metabolic and cardiovascular markers
• Enable simple oral administration
• Maintain tolerability standards comparable to injectable GLP-1 therapies.